Business Context and Reporting Period
This Form 8-K is a Current Report filed by Landec Corporation (not Lifecore Biomedical, Inc.) on April 3, 2019. The filing announces the consolidated financial results for the third quarter of fiscal year 2019. The detailed financial data is contained in a press release furnished as Exhibit 99.1, which is not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1), but the content of that exhibit is not present in the source material.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the third quarter of fiscal year 2019 were announced.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The report explicitly states that the information in the press release is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, as the request metadata incorrectly listed "LIFECORE BIOMEDICAL, INC."
- Locate and review Exhibit 99.1 (the press release) to obtain actual financial figures for the third quarter of fiscal year 2019.
- Confirm the fiscal year end date for Landec Corporation to accurately compare the reported quarter against prior periods.
- Note that the financial data in the press release is not incorporated by reference into this 8-K filing.